Risk Factors for Development of and Progression of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome

Biology of Blood and Marrow Transplantation - Netherlands
doi 10.1016/j.bbmt.2019.02.018
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Recent Developments With Defibrotide for the Treatment of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome

Expert Opinion on Orphan Drugs
ToxicologyPharmaceuticsPharmacologyHealth Policy
2019English

Defibrotide for Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome With Multi-Organ Dysfunction: A Concordance Analysis Between Day+100 Complete Response and Survival

Biology of Blood and Marrow Transplantation
TransplantationHematology
2016English

Risk Factors for Hepatic Veno-Occlusive Disease Caused by Gynura Segetum: A Retrospective Study

BMC Gastroenterology
MedicineGastroenterology
2018English

Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome in Patients With Prior Gemtuzumab Ozogamicin: Literature Analysis of Survival After Defibrotide Treatment

Blood Cancer Journal
OncologyHematology
2020English

Incidence of Anicteric Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome and Outcomes With Defibrotide Following Hematopoietic Cell Transplantation in Adult and Pediatric Patients

Biology of Blood and Marrow Transplantation
TransplantationHematology
2020English

Hepatic Veno-Occlusive Disease: Report of a Case

Jornal de Pediatria
Child HealthPediatricsPerinatology
1997English

Efficacy and Safety of Defibrotide in a Subset Analysis of Late-Onset Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome (VOD/SOS) Patients From an Ongoing, Expanded-Access Program

Biology of Blood and Marrow Transplantation
TransplantationHematology
2016English

Earlier Defibrotide Initiation Post-Diagnosis of Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome Improves Day +100 Survival Following Haematopoietic Stem Cell Transplantation

British Journal of Haematology
Hematology
2017English

Defibrotide Cost-Effectiveness in Canada for the Treatment of Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome (VOD/SOS) With Multi-Organ Dysfunction (MOD) After HSCT

Biology of Blood and Marrow Transplantation
TransplantationHematology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy